You've received your blood test results and ALP is flagged as high. Before you search online and encounter a list of alarming possibilities, it helps to understand what alkaline phosphatase actually is and — crucially — how to interpret it alongside the other values on your panel.
ALP is an enzyme found in several organs: the lining of your bile ducts, bone, kidneys, intestines, and placenta. This multi-organ origin is what makes it tricky: a high ALP value is not a diagnosis — it is a clue that requires context. The single most important accompanying test is GGT. Together, ALP and GGT are far more informative than either one alone.
This guide covers what ALP measures, its normal ranges at different life stages, how to distinguish hepatic from non-hepatic causes, the clinical patterns seen in common liver diseases, and when an elevated ALP genuinely needs urgent attention.
What Is ALP and What Does It Measure?
Alkaline phosphatase (ALP) is an enzyme that catalyses the hydrolysis of phosphate groups from various molecules, and it does so most efficiently in an alkaline environment — hence its name. In clinical practice, serum ALP reflects the sum of contributions from several isoenzyme sources:
| ALP Isoenzyme Source | Relative Contribution (Adult) | Clinical Relevance |
|---|---|---|
| Liver (biliary epithelium) | ~50% | Rises with bile duct obstruction or cholestatic disease |
| Bone (osteoblasts) | ~40% | Rises with bone turnover: growth, fractures, Paget's, bone metastases |
| Intestinal epithelium | ~10% | Higher after fatty meals; elevated in blood group O/B individuals |
| Placenta | Variable | Physiologically elevated in 2nd–3rd trimester of pregnancy |
| Kidney (rare) | Minimal | Usually clinically insignificant |
Standard laboratory tests measure total serum ALP — the combined signal from all sources. This is why an elevated ALP does not automatically point to the liver. The clinical interpretation requires understanding which source is likely elevated given your age, sex, and accompanying test results.
Normal ALP Ranges by Age and Sex
Understanding ALP reference ranges requires knowing that normal values shift dramatically across the lifespan — more so than almost any other routine liver test:
| Age / Sex Group | Typical ALP Range (U/L) | Reason for Range |
|---|---|---|
| Infants (0–1 yr) | 60–400 U/L | Very rapid bone growth; liver ALP also elevated |
| Children (1–10 yr) | 100–350 U/L | Ongoing skeletal development and bone turnover |
| Adolescents (pubertal growth spurt) | Up to 500–700 U/L | Peak bone ALP from osteoblast activity; completely physiological |
| Adult women (18–50 yr) | 35–104 U/L | Lower bone turnover in premenopausal adults |
| Adult men (18–50 yr) | 40–129 U/L | Slightly higher due to liver isoenzyme contribution |
| Adults over 65 | Typically 30–130 U/L; can be higher | Increases again with age-related bone remodelling |
| Pregnancy (2nd–3rd trimester) | May reach 2–4× normal | Placental ALP isoenzyme; entirely physiological |
The take-home: a "high" ALP in a 14-year-old in a growth spurt is almost always physiological bone ALP and requires no further workup. The same value in a 55-year-old with known liver disease has entirely different implications. Always interpret ALP in the context of age, sex, pregnancy status, and other test results.
Liver vs. Bone: How to Tell the Difference
When ALP is elevated in a non-pregnant, non-adolescent adult, the first question is always: liver or bone? The simplest approach uses a single additional test — GGT:
GGT is not found in bone tissue at all. This makes it an excellent discriminator: GGT elevation essentially confirms a hepatic or biliary source for the ALP rise. In contrast, GGT is normal in bone disease, pregnancy (placental ALP), and intestinal ALP elevation.
If confirmation is needed beyond the GGT check, laboratories can fractionate ALP into its isoenzyme components, or measure bone-specific ALP (BALP) as a direct marker of osteoblast activity. In practice, the GGT approach is sufficient for most clinical decisions.
ALP vs. Other Liver Enzymes: The Pattern Matters
| Enzyme Pattern | Most Likely Interpretation | Primary Concern |
|---|---|---|
| ALP ↑↑ + GGT ↑↑, ALT/AST normal or mildly ↑ | Cholestatic pattern | PBC, PSC, bile duct obstruction, drug-induced cholestasis |
| ALT/AST ↑↑ + ALP mildly ↑, GGT variable | Hepatocellular pattern | Hepatitis (viral, autoimmune, drug-induced), MASLD, alcohol |
| ALP ↑↑ + GGT ↑↑ + ALT/AST ↑↑ (mixed) | Mixed hepatocellular-cholestatic | Drug-induced liver injury (DILI), some viral hepatitis patterns |
| ALP ↑, GGT normal, calcium and phosphate abnormal | Bone disease | Paget's disease, bone metastases, vitamin D deficiency, hyperparathyroidism |
| ALP mildly ↑, GGT normal, adolescent or pregnant patient | Physiological | Growth spurt (adolescent), placental ALP (pregnancy) — no action needed |
What Causes Elevated ALP?
Hepatic and Biliary Causes
When ALP elevation originates from the liver, the underlying problem is almost always related to the bile ducts rather than the hepatocytes themselves. This is called a cholestatic pattern. The most important conditions to consider, roughly ordered by urgency:
| Condition | Typical ALP Level | Key Accompanying Features |
|---|---|---|
| Bile duct obstruction (gallstone, stricture, tumour) | 3–10× ULN, can be higher | Jaundice, right upper quadrant pain, dilated ducts on imaging |
| Primary biliary cholangitis (PBC) | 3–10× ULN typical | Fatigue, itch (pruritus), anti-mitochondrial antibody (AMA) positive |
| Primary sclerosing cholangitis (PSC) | 3–10× ULN typical | IBD association; beaded bile ducts on MRCP |
| Drug-induced cholestasis | 1–5× ULN | Onset after starting new medication (antibiotics, antifungals, OCPs) |
| Hepatocellular carcinoma (HCC) or metastases | Variable, often elevated | Known malignancy, elevated AFP, liver lesion on imaging |
| Infiltrative liver disease (sarcoidosis, lymphoma, amyloid) | Often markedly elevated | Disproportionate ALP vs. transaminases; multi-organ involvement |
| MASLD / fatty liver | Mildly elevated (1–2× ULN) | ALT/GGT more prominent; ALP alone not a primary marker |
| Cirrhosis | Variable; may fall in end-stage | Low albumin, elevated INR, thrombocytopenia |
Non-Hepatic Causes
| Non-Hepatic Cause | Typical ALP Level | Distinguishing Features |
|---|---|---|
| Paget's disease of bone | Can be markedly elevated (5–10× ULN) | GGT normal; bone pain; skull/pelvis changes on X-ray |
| Bone metastases | Often 3–5× ULN | Known malignancy; GGT normal; bone scan positive |
| Vitamin D deficiency / osteomalacia | Mildly elevated | Low 25-OHD, elevated PTH; GGT normal |
| Hyperparathyroidism | Mildly elevated | High calcium, high PTH; GGT normal |
| Pregnancy (2nd–3rd trimester) | Up to 2–4× ULN | Placental isoenzyme; resolves postpartum; GGT normal |
| Puberty / adolescent growth | Up to 5× adult ULN | Age-appropriate; GGT normal; entirely physiological |
ALP in Specific Liver Conditions
ALP in MASLD (Fatty Liver Disease)
In MASLD, ALP is usually only mildly elevated or entirely normal. It is not a primary marker of fatty liver disease activity — that role belongs to ALT and GGT. The presence of a markedly elevated ALP in a patient with known fatty liver should trigger investigation for a concurrent problem: biliary disease, drug-induced cholestasis, hepatocellular carcinoma, or a second liver condition. Do not attribute significant ALP elevation to fatty liver alone.
ALP in Primary Biliary Cholangitis (PBC)
PBC is an autoimmune condition that destroys the small bile ducts within the liver. ALP elevation — often 3–10× ULN — alongside anti-mitochondrial antibody (AMA) positivity is diagnostic in most cases. GGT is also elevated. Importantly, treatment with ursodeoxycholic acid (UDCA) normalises or substantially reduces ALP in most PBC patients, and ALP response at one year is the primary surrogate marker for treatment success and long-term prognosis.
ALP in Hepatocellular Carcinoma (HCC)
ALP can be elevated in HCC both because of the tumour's infiltration of liver tissue and because tumours may produce their own ALP isoenzyme (sometimes called Regan isoenzyme). A rising ALP in a patient with chronic liver disease or cirrhosis — particularly when disproportionate to other enzymes — should prompt imaging review and AFP measurement to exclude HCC.
ALP in Cirrhosis
ALP behaviour in cirrhosis is variable. It may be elevated due to ongoing biliary inflammation or portal hypertension, but in end-stage cirrhosis, ALP may paradoxically normalise or fall as the liver loses the capacity to produce it. A "normal" ALP in a patient with severely impaired albumin and elevated INR does not indicate biliary health — it may indicate hepatic exhaustion.
What to Do If Your ALP Is Elevated
The appropriate response depends entirely on how elevated it is, whether GGT is also elevated, and your clinical context. Here is a practical framework:
| ALP Level | GGT Status | Recommended Next Steps |
|---|---|---|
| Mildly elevated (1–2× ULN) | GGT normal; adolescent or pregnant patient | No immediate action; physiological — recheck in 3–6 months if persistent |
| Mildly elevated (1–2× ULN) | GGT also elevated | Liver ultrasound; review medications; check for MASLD |
| Moderately elevated (2–4× ULN) | GGT elevated | Liver ultrasound, MRCP if ducts appear abnormal; consider AMA antibody for PBC |
| Markedly elevated (>4× ULN) | Any | Urgent hepatology referral; liver ultrasound, MRCP; AMA, p-ANCA; AFP |
| Any level, rising trend | Any | Escalate investigation; a rising ALP is more concerning than a stable mildly elevated ALP |
| High ALP, GGT normal, not pregnant/adolescent | GGT normal | Check bone panel: calcium, phosphate, 25-OHD, PTH; consider bone scan |
Frequently Asked Questions
ALP (alkaline phosphatase) is an enzyme found primarily in the liver (bile duct lining), bone, kidneys, and intestines. In a standard blood test panel, elevated ALP most commonly signals either cholestatic liver disease (impaired bile flow) or increased bone turnover. The standard adult reference range is approximately 30–120 U/L, though this varies significantly with age, sex, and the specific laboratory's reference values.
The most practical approach is to check GGT simultaneously. GGT is not found in bone — so if both ALP and GGT are elevated, the source is almost certainly hepatic or biliary. If ALP is elevated but GGT is entirely normal, bone disease, pregnancy, or adolescent growth is the more likely explanation. If further confirmation is needed, ALP isoenzyme fractionation or a bone-specific ALP test can identify the exact source.
Yes, but only mildly. In MASLD, ALP may be 1–2× the upper limit of normal at most, and ALT and GGT are usually more prominently elevated. If your ALP is markedly elevated (more than 3–4× ULN) and your diagnosis is fatty liver, this should prompt investigation for a concurrent biliary problem, drug-induced liver injury, or liver tumour rather than attributing it to the steatosis alone. Significantly elevated ALP is not a typical feature of simple fatty liver.
ALP greater than 4× the upper limit of normal is a significant finding that strongly suggests cholestatic liver disease or biliary obstruction. The most important conditions to investigate at this level include: primary biliary cholangitis (PBC) — tested with AMA antibody; primary sclerosing cholangitis (PSC) — tested with MRCP imaging; bile duct obstruction from gallstones, stricture, or tumour — visible on ultrasound or MRCP; drug-induced cholestasis; and infiltrative liver disease. Hepatology referral is appropriate at this level.
Not necessarily. Mildly elevated ALP (1–2× ULN) in an adolescent, pregnant woman, or older adult without other abnormal liver tests is usually physiological and requires no immediate action beyond monitoring. However, if GGT is also elevated, or if the ALP is rising over serial measurements, further workup for liver or biliary disease is indicated. The trend matters as much as the absolute value — a slowly rising ALP over multiple years is more concerning than a stable mild elevation.
Both ALP and GGT are markers of biliary or cholestatic disease and often rise together. The key difference is specificity and organ distribution. ALP comes from multiple organs (liver, bone, intestine, placenta), making it less specific for liver disease on its own. GGT is found primarily in the liver and biliary tree, making it a more specific marker of liver involvement when elevated. GGT is also highly sensitive to alcohol and induction by drugs like phenytoin. Together, they form the most useful pairing in interpreting a cholestatic enzyme pattern. See our full liver enzymes guide for a detailed comparison of all four enzymes.
Go Deeper on Liver Enzyme Interpretation
Our full liver enzymes guide covers AST, ALT, ALP, and GGT together — including the De Ritis ratio, optimised ALT cutoffs, and clinical interpretation patterns — backed by current ACG and EASL guidelines.
Read Liver Enzymes Guide Bilirubin, Albumin & INR